{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T06:39:39Z","timestamp":1784356779966,"version":"3.55.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2020,6,23]],"date-time":"2020-06-23T00:00:00Z","timestamp":1592870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,6,23]],"date-time":"2020-06-23T00:00:00Z","timestamp":1592870400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs Aging"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1007\/s40266-020-00776-9","type":"journal-article","created":{"date-parts":[[2020,6,23]],"date-time":"2020-06-23T16:19:42Z","timestamp":1592929182000},"page":"463-468","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Recent Advances in the Management of Migraine in Older Patients"],"prefix":"10.1007","volume":"37","author":[{"given":"Payal P.","family":"Soni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasima","family":"Shadbehr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7580-7453","authenticated-orcid":false,"given":"Zubair A.","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,23]]},"reference":[{"issue":"2","key":"776_CR1","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/j.1468-2982.2006.01250.x","volume":"27","author":"J Haan","year":"2007","unstructured":"Haan J, Hollander J, Ferrari M. Migraine in the elderly: a review. Cephalalgia. 2007;27(2):97\u2013106.","journal-title":"Cephalalgia"},{"issue":"3","key":"776_CR2","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/S0304-3959(99)00057-3","volume":"82","author":"S-J Wang","year":"1999","unstructured":"Wang S-J, Liu H-C, Fuh J-L, Liu C-Y, Wang P-N, Lu S-R. Comorbidity of headaches and depression in the elderly. Pain. 1999;82(3):239\u201343.","journal-title":"Pain"},{"issue":"1","key":"776_CR3","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1017\/S0317167100024690","volume":"7","author":"CM Fisher","year":"1980","unstructured":"Fisher CM. Late-life migraine accompaniments as a cause of unexplained transient ischemic attacks. Can J Neurol Sci. 1980;7(1):9\u201317.","journal-title":"Can J Neurol Sci"},{"issue":"4","key":"776_CR4","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/nrneurol.2009.28","volume":"5","author":"A May","year":"2009","unstructured":"May A. New insights into headache: an update on functional and structural imaging findings. Nat Rev Neurol. 2009;5(4):199\u2013209.","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"776_CR5","doi-asserted-by":"publisher","first-page":"67","DOI":"10.11607\/ofph.1866","volume":"32","author":"S Celle","year":"2018","unstructured":"Celle S, Cr\u00e9ac\u2019h C, Boutet C, Roche F, Chouchou F, Barth\u00e9l\u00e9my J-C, et al. Elderly patients with ongoing migraine show reduced gray matter volume in second somatosensory cortex. J Oral Facial Pain Headache. 2018;32(1):67\u201374.","journal-title":"J Oral Facial Pain Headache"},{"issue":"2","key":"776_CR6","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1093\/gerona\/glr118","volume":"67A","author":"AJ McLachlan","year":"2012","unstructured":"McLachlan AJ, Pont LG. Drug metabolism in older people: a key consideration in achieving optimal outcomes with medicines. J Gerontol A Biol Sci Med Sci. 2012;67A(2):175\u201380.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"1","key":"776_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/14656566.2018.1543660","volume":"20","author":"M Curto","year":"2019","unstructured":"Curto M, Capi M, Martelletti P, Lionetto L. How do you choose the appropriate migraine pharmacotherapy for an elderly person? Expert Opin Pharmacother. 2019;20(1):1\u20133.","journal-title":"Expert Opin Pharmacother"},{"issue":"6","key":"776_CR8","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1177\/0333102414547138","volume":"35","author":"Z Hepp","year":"2015","unstructured":"Hepp Z, Dodick DW, Varon SF, Gillard P, Hansen RN, Devine EB. Adherence to oral migraine-preventive medications among patients with chronic migraine. Cephalalgia. 2015;35(6):478\u201388.","journal-title":"Cephalalgia"},{"issue":"7","key":"776_CR9","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1111\/head.12870","volume":"56","author":"T Pringsheim","year":"2016","unstructured":"Pringsheim T, Davenport WJ, Marmura MJ, Schwedt TJ, Silberstein S. How to apply the AHS evidence assessment of the acute treatment of migraine in adults to your patient with migraine. Headache. 2016;56(7):1194\u2013200.","journal-title":"Headache"},{"issue":"8","key":"776_CR10","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1111\/head.13601","volume":"59","author":"PG Mathew","year":"2019","unstructured":"Mathew PG, Klein BC. Getting to the heart of the matter: migraine, triptans, DHE, ditans, CGRP antibodies, first\/second-generation gepants, and cardiovascular risk. Headache. 2019;59(8):1421\u20136.","journal-title":"Headache"},{"issue":"20","key":"776_CR11","doi-asserted-by":"publisher","first-page":"e2309","DOI":"10.1212\/WNL.0000000000007497","volume":"92","author":"SJ Tepper","year":"2019","unstructured":"Tepper SJ, Diener H-C, Ashina M, Brandes JL, Friedman DI, Reuter U, et al. Erenumab in chronic migraine with medication overuse: subgroup analysis of a randomized trial. Neurology. 2019;92(20):e2309\u2013e23202320.","journal-title":"Neurology"},{"issue":"2","key":"776_CR12","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1056\/NEJMoa1811090","volume":"381","author":"RB Lipton","year":"2019","unstructured":"Lipton RB, Croop R, Stock EG, Stock DA, Morris BA, Frost M, et al. Rimegepant, an oral calcitonin gene-related peptide receptor antagonist, for migraine. N Engl J Med. 2019;381(2):142\u20139.","journal-title":"N Engl J Med"},{"key":"776_CR13","first-page":"1","volume":"59","author":"R Croop","year":"2019","unstructured":"Croop R, Stringfellow J, Ivans A, Coric V. The pharmacokinetics, safety, and tolerability of rimegepant 75 mg are similar in elderly and nonelderly adults: a phase 1, open-label, parallel-group, single-dose study. Headache. 2019;59:1\u2013208.","journal-title":"Headache"},{"key":"776_CR14","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1111\/head.12601","volume":"55","author":"C Cameron","year":"2015","unstructured":"Cameron C, Kelly S, Hsieh S-C, Murphy M, Chen L, Kotb A, et al. Triptans in the acute treatment of migraine: a systematic review and network meta-analysis. Headache. 2015;55:221\u201335.","journal-title":"Headache"},{"issue":"1","key":"776_CR15","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1161\/01.CIR.98.1.25","volume":"98","author":"A MaassenVanDenBrink","year":"1998","unstructured":"MaassenVanDenBrink A, Reekers M, Bax WA, Ferrari MD, Saxena PR. Coronary side-effect potential of current and prospective antimigraine drugs. Circulation. 1998;98(1):25\u201330.","journal-title":"Circulation"},{"key":"776_CR16","unstructured":"U.S. Department of Justice, Drug Enforcement Administration, Diversion Control Division. 2020\u2014placement of lasmiditan in Schedule V. https:\/\/www.deadiversion.usdoj.gov\/fed_regs\/rules\/2020\/fr0131.htm. Accessed 26 Mar 2020."},{"issue":"4","key":"776_CR17","doi-asserted-by":"publisher","first-page":"e364","DOI":"10.1212\/WNL.0000000000005857","volume":"91","author":"C Tassorelli","year":"2018","unstructured":"Tassorelli C, Grazzi L, de Tommaso M, Pierangeli G, Martelletti P, Rainero I, et al. Noninvasive vagus nerve stimulation as acute therapy for migraine: the randomized PRESTO study. Neurology. 2018;91(4):e364\u2013e373373.","journal-title":"Neurology"},{"issue":"13","key":"776_CR18","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1212\/WNL.0000000000003760","volume":"88","author":"D Yarnitsky","year":"2017","unstructured":"Yarnitsky D, Volokh L, Ironi A, Weller B, Shor M, Shifrin A, et al. Nonpainful remote electrical stimulation alleviates episodic migraine pain. Neurology. 2017;88(13):1250\u20135.","journal-title":"Neurology"},{"key":"776_CR19","first-page":"2516953","volume":"2018","author":"M Binfalah","year":"2018","unstructured":"Binfalah M, Alghawi E, Shosha E, Alhilly A, Bakhiet M. Sphenopalatine ganglion block for the treatment of acute migraine headache. Pain Res Treat. 2018;2018:2516953.","journal-title":"Pain Res Treat"},{"issue":"6","key":"776_CR20","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1136\/jnnp.2007.134023","volume":"7","author":"DW Dodick","year":"2007","unstructured":"Dodick DW, Silberstein SD. Migraine prevention. Pract Neurol. 2007;7(6):383\u201393.","journal-title":"Pract Neurol"},{"issue":"3","key":"776_CR21","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1177\/0333102420905132","volume":"40","author":"M Ashina","year":"2020","unstructured":"Ashina M, Saper J, Cady R, Schaeffler BA, Biondi DM, Hirman J, et al. Eptinezumab in episodic migraine: a randomized, double-blind, placebo-controlled study (PROMISE-1). Cephalalgia. 2020;40(3):241\u201354. https:\/\/doi.org\/10.1177\/0333102420905132.","journal-title":"Cephalalgia"},{"issue":"3","key":"776_CR22","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1097\/WCO.0000000000000806","volume":"33","author":"D Moreno-Ajona","year":"2020","unstructured":"Moreno-Ajona D, P\u00e9rez-Rodr\u00edguez A, Goadsby PJ. Gepants, calcitonin-gene-related peptide receptor antagonists: what could be their role in migraine treatment? Curr Opin Neurol. 2020;33(3):309\u201315.","journal-title":"Curr Opin Neurol"},{"issue":"7","key":"776_CR23","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1111\/head.13120","volume":"57","author":"D Wilkinson","year":"2017","unstructured":"Wilkinson D, Ade KK, Rogers LL, Attix DK, Kuchibhatla M, Slade MD, et al. Preventing episodic migraine with caloric vestibular stimulation: a randomized controlled trial. Headache. 2017;57(7):1065\u201387.","journal-title":"Headache"}],"container-title":["Drugs & Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-020-00776-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40266-020-00776-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-020-00776-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,22]],"date-time":"2021-06-22T23:20:39Z","timestamp":1624404039000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40266-020-00776-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,23]]},"references-count":23,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["776"],"URL":"https:\/\/doi.org\/10.1007\/s40266-020-00776-9","relation":{},"ISSN":["1170-229X","1179-1969"],"issn-type":[{"value":"1170-229X","type":"print"},{"value":"1179-1969","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,23]]},"assertion":[{"value":"23 June 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"No sources of funding were received for the preparation of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Payal P. Soni, Michelle Lee, and Nasima Shadbehr have no conflicts of interest that are directly relevant to the content of this article. Zubair A. Ahmed has received consulting fees from Eli Lilly, Amgen, Allergan, and ElectroCore. He has served as a speaker for Allergan and has received funding for an investigator-initiated trial from Teva.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}